– On Semiconductor fell 1.03% on 8/15 with 363rd volume rank as Eli Lilly raised Mounjaro’s UK price by 170% to £330/month.
– Price hike aligns UK with European markets and responds to Trump-era U.S. pricing pressures while maintaining NHS patient access.
– Analysts link pharma pricing shifts to cross-sector market sentiment, highlighting regulatory risks and affordability concerns for non-NHS patients.
– Top-500 volume trading strategy showed 0.98% daily average returns but emphasized short-term volatility risks without fundamental analysis.